Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EMBC

Embecta Corp

3.43

Jul 27 • 3:59 PM ET +0.14 (4.41%)

3.43

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Medical Instruments & Supplies USA Micro NASD

Peers: OSUR LMAT ICUI MASS MMSI TFX VMD RMD BFLY VCYT

| Held by: VTI IWM VXF IWN FNDA VTWO DES SCHA VFVA ISMD

Scroll to Statements

Index	RUT
Market Cap	203.79M
Enterprise Value	1.38B
Income	111.90M
Sales	1.04B
Book/sh	-10.55
Cash/sh	3.26
Dividend Est.	0.25 (7.27%)
Dividend TTM	0.46 (13.39%)
Dividend Ex-Date	May 28, 2026
Dividend Gr. 3/5Y	58.74% -
Payout	37.05%
Employees	1850
IPO	Mar 22, 2022

P/E	1.81
Forward P/E	1.98
PEG	-
P/S	0.20
P/B	-
P/C	1.05
P/FCF	1.00
EV/EBITDA	3.80
EV/Sales	1.33
Quick Ratio	1.68
Current Ratio	2.46
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	1.90
EPS next Y	1.74
EPS next Q	0.27
EPS this Y	-45.99%
EPS next Y	9.15%
EPS next 5Y	-13.14%
EPS past 3/5Y	-25.52% -
Sales past 3/5Y	-1.47% -0.10%
EPS Y/Y TTM	109.76%
Sales Y/Y TTM	-3.43%
EPS Q/Q	-117.21%
Sales Q/Q	-14.36%
Earnings	Aug 07 BMO
EPS/Sales Surpr.	-35.25% -5.89%

Insider Own	7.85%
Insider Trans	0.00%
Inst Own	93.05%
Inst Trans	-10.21%
ROA	10.41%
ROE	-
ROIC	15.38%
Gross Margin	62.52%
Oper. Margin	29.78%
Profit Margin	10.73%
SMA20	4.56%
SMA50	5.92%
SMA200	-61.95%
Trades

Shs Outstand	59.33M
Shs Float	54.67M
Short Float	11.02%
Short Ratio	2.36
Short Interest	6.03M
52W High	15.55 -77.91%
52W Low	2.77 24.01%
Volatility	3.99% 4.81%
ATR (14)	0.17
RSI (14)	52.85
Beta	0.80
Rel Volume	0.34
Avg Volume	2.55M
Volume	875,192

Perf Week	-0.15%
Perf Month	10.45%
Perf Quarter	-62.74%
Perf Half Y	-68.60%
Perf YTD	-71.09%
Perf Year	-70.72%
Perf 3Y	-83.80%
Perf 5Y	-
Perf 10Y	-
Recom	3.25
Target Price	4.00
Prev Close	3.29
Price	3.43
Change	4.41%

Date	Action	Analyst	Rating Change	Price Target Change
May-06-26	Downgrade	BTIG Research	Buy → Neutral
Apr-10-25	Initiated	Mizuho	Neutral	$15
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Today 04:40AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire)
Jul-23-26 05:00PM	embecta to Report Fiscal Third Quarter Financial Results (GlobeNewswire)
Jul-21-26 08:30AM	Kaplan Fox Encourages Investors of Embecta Corp. (EMBC) Who Suffered Losses to Contact the Firm Before August 17, 2026 (Newsfile)
Jun-25-26 05:23AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC (PR Newswire)
Jun-18-26 10:36AM	Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights EMBC (Business Wire)
06:30AM	Loading…
Jun-16-26 06:30AM	embecta appoints Nimish Muzumdar as SVP and President, North America (GlobeNewswire)
Jun-05-26 07:25PM	Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Jun-01-26 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.08%
May-21-26 08:20PM	Levi & Korsinsky Investigating Whether Embecta Corp. (EMBC) Misled Investors - Securities Law Violations Possible (Newsfile) +8.50%
May-18-26 07:13AM	Embecta acquires Owen Mumford for $172.6m (Medical Device Network)
07:10AM	Embecta closes Owen Mumford acquisition for up to $201M (MedTech Dive)
May-15-26 09:00AM	embecta Completes Acquisition of Owen Mumford Holdings Limited (GlobeNewswire)
May-08-26 09:00AM	embecta to Participate at the 2026 BofA Securities Global Health Care Conference (GlobeNewswire)
May-05-26 04:53PM	Embecta Corp. Q2 2026 Earnings Call Summary (Moby) -57.84% -8.72%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:30AM	Loading…
06:30AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Apr-21-26 05:00PM	embecta to Report Fiscal Second Quarter Financial Results (GlobeNewswire)
Mar-20-26 06:35AM	Embecta agrees to acquire Owen Mumford (Medical Device Network)
Mar-19-26 10:37AM	Embecta to buy Owen Mumford for up to $201M (MedTech Dive)
06:30AM	embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited (GlobeNewswire)
Feb-11-26 04:10PM	embecta names new Chairman of the Board and Lead Independent Director (GlobeNewswire)
Feb-05-26 05:30PM	Embecta Q1 Earnings Call Highlights (MarketBeat) -7.75%
02:02PM	Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-22-26 05:00PM	embecta to Report Fiscal First Quarter Financial Results (GlobeNewswire) -9.44%
Dec-18-25 05:00PM	embecta to Participate at the J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Nov-25-25 02:01PM	Embecta Corp (EMBC) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) -7.24%
06:30AM	Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
07:50AM	Loading…
Nov-20-25 07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
Nov-17-25 05:00PM	embecta announces changes to Board of Directors (GlobeNewswire)
Nov-14-25 06:30AM	embecta Announces Major New Commitment to Direct Relief on World Diabetes Day (GlobeNewswire)
Nov-11-25 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Oct-06-25 05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Sep-15-25 08:06AM	Best Income Stocks to Buy for September 15th (Zacks)
05:37AM	New Strong Buy Stocks for September 15th (Zacks)
Sep-09-25 04:12AM	Best Value Stocks to Buy for September 9th (Zacks)
Aug-26-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Aug-25-25 09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Aug-12-25 09:55AM	Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know (Zacks)
Aug-09-25 03:03AM	Embecta Corp (EMBC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Progress ... (GuruFocus.com)
Aug-08-25 06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) +18.53%
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-24-25 05:00PM	embecta to Report Fiscal Third Quarter 2025 Financial Results (GlobeNewswire)
Jul-13-25 12:27AM	BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating (Insider Monkey)
Jul-10-25 11:13AM	Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating (Insider Monkey)
May-27-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +5.09% -6.31%
May-22-25 06:30AM	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire) -14.97%
May-13-25 10:50AM	Embecta restructures again, outlines tariff costs (MedTech Dive)
May-10-25 05:16AM	Q2 2025 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
May-09-25 12:10PM	Why Is Embecta Stock Falling On Friday? (Benzinga) -10.00%
07:40AM	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-08-25 05:15PM	Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates (Zacks) +6.66%
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
Apr-28-25 07:30AM	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire)
Apr-22-25 03:51AM	Beyond the drug: Closing the knowledge gap for injectable diabetes meds (Pharma Voice)
Apr-21-25 05:00PM	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire)
Apr-01-25 08:05AM	Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations (GlobeNewswire)
Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

PresidentMr. Devdatt Kurdikar Ph.D.

Senior VP & CFOMr. Jacob P. Elguicze

Senior VPMr. Jeffrey Z. Mann

Senior VP & Chief Human Resources OfficerMs. Jean M. Casner

Senior Vice President of Global Manufacturing & Supply ChainMr. Shaun Curtis

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your Finviz experience